BUZZ-Veeva climbs after J.P. Morgan upgrades to 'overweight'

Reuters
Sep 08
BUZZ-<a href="https://laohu8.com/S/VEEV">Veeva</a> climbs after J.P. Morgan upgrades to 'overweight'

** Shares of healthcare tech firm Veeva Systems VEEV.N rise ~1.4% to $276.7 premarket

** J.P. Morgan upgrades stock rating to "overweight" from "neutral"; raises PT to $330 from $290

** Brokerage says it is optimistic about new opportunities created by Veeva's partnership with IQVIA IQV.N (formerly IMS Health and Quintiles) and its use of Agentic Artificial Intelligence $(AI)$

** Last month, IQVIA and Veeva announced long-term partnerships covering both clinical and commercial areas, along with resolution of all outstanding disputes

** Veeva competes with Salesforce CRM.N and other software providers, but no one matches its product depth, especially across Vault CRM Suites, brokerage says

** Stock rated "buy" on average; median PT is $322 - data compiled by LSEG

** As of last close, VEEV has risen ~30% this year

(Reporting by Akriti Shah in Bengaluru)

((akriti.shah@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10